Patel Anish

CIK 00019671631 companyBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001967163

Recent Transactions

50 trades

Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-09$28.50/sh−243→ 215,011 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-09$27.98/sh−48,057→ 215,254 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-12-08$21.78/sh−1,705→ 263,311 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-12-08$20.76/sh−4,958→ 265,016 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-11-07$17.94/sh−613→ 269,974 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-11-07$17.35/sh−6,054→ 270,587 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-10-07$20.10/sh−6,667→ 276,641 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-08$20.24/sh−6,667→ 283,308 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-07$18.93/sh−405→ 289,975 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-07$18.20/sh−6,262→ 290,380 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-07$19.75/sh−6,362→ 296,947 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-07$20.69/sh−305→ 296,642 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-09$20.33/sh−6,607→ 303,369 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-09$21.16/sh−60→ 303,309 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-07$19.40/sh−390→ 310,080 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-07$19.87/sh−104→ 309,976 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-07$18.30/sh−6,173→ 310,470 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-07$19.27/sh−148→ 316,643 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-07$18.29/sh−2,763→ 316,791 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-07$17.81/sh−3,756→ 319,554 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-07$21.44/sh−6,667→ 323,310 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-02-07$21.93/sh−6,667→ 329,977 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2025-01-07−10,700→ 67 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$2.48/sh+9,000→ 21,700 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$24.56/sh−1,440→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$2.48/sh+2,000→ 12,700 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2025-01-07−2,000→ 827 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$24.60/sh−90→ 336,644 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$1.12/sh+10,700→ 10,700 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$24.15/sh−20,260→ 1,440 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-07$24.17/sh−6,577→ 336,734 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2025-01-07−9,000→ 44,342 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−716→ 343,311 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-16$25.01/sh−1,547→ 344,027 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-15$25.05/sh−30,978→ 345,574 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-12$25.07/sh−17,475→ 376,552 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-06-06$20.06/sh−1,133→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2024-06-06−1,133→ 53,342 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-06-06$2.48/sh+1,133→ 1,133 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2024-05-14−1,107→ 54,475 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-14$25.00/sh−1,107→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-14$2.48/sh+1,107→ 1,107 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-09$25.06/sh−260→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-09$2.48/sh+260→ 260 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2024-05-09−260→ 55,582 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-06$2.48/sh+4,875→ 4,875 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-06$22.72/sh−4,875→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2024-05-06−4,875→ 55,842 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.03/sh−17,500→ 0 total

Companies

Enliven Therapeutics, Inc.
CHIEF OPERATING OFFICER
$ELVN

Recent Filings

Address

C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD

BOULDER, CO, 80301

View on SEC.gov